Lineage (NASDAQ:LINE) Downgraded to “Underperform” Rating by BNP Paribas Exane
Lineage (NASDAQ:LINE – Get Free Report) was downgraded by investment analysts at BNP Paribas Exane from a “neutral” rating to an “underperform” rating in a research note issued on Thursday, MarketBeat Ratings reports. They currently have a $42.00 target price on the stock. BNP Paribas Exane’s price target points to a potential downside of 3.78% […]
Lineage (NASDAQ:LINE – Get Free Report) was downgraded by investment analysts at BNP Paribas Exane from a “neutral” rating to an “underperform” rating in a research note issued on Thursday, MarketBeat Ratings reports. They currently have a $42.00 target price on the stock. BNP Paribas Exane’s price target points to a potential downside of 3.78% […]
